Lidocaine inhibits staphylococcal enterotoxin-stimulated activation of peripheral blood mononuclear cells from patients with atopic dermatitis
Authors:
Open Access
- 16 April 2013
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 305 (7) , 629-636
Abstract
Atopic dermatitis (AD) is an inflammatory, chronically relapsing, pruritic skin disease and lesions associated with AD are frequently colonized with Staphylococcus aureus (S. aureus). Activation of T cells by staphylococcal enterotoxins (SE) plays a crucial role in the pathogenesis of AD. Previous studies have demonstrated that lidocaine could attenuate allergen-induced T cell proliferation and cytokine production in peripheral blood mononuclear cells (PBMCs) from asthma patients. The purpose of this study was to investigate the effects of lidocaine on SE-stimulated activation of PBMCs from AD patients. PBMCs were isolated from ten AD patients and stimulated by staphylococcal enterotoxin A (SEA) or staphylococcal enterotoxin B (SEB) in the presence or absence of lidocaine in various concentrations. Cellular proliferation and the release of representative TH1- and TH2-type cytokines were measured. The effect of lidocaine on filaggrin (FLG) expression in HaCaT cells co-cultured with SE-activated PBMCs was also examined. Our results demonstrated that lidocaine dose-dependently inhibited the proliferative response and the release of IL-4, IL-5, IL-13, TNF-α, and IFN-γ from SEA- and SEB-stimulated PBMCs and also blocked the down-regulation of FLG expression in HaCaT cells co-cultured with SEA- and SEB-activated PBMCs. These results indicate that lidocaine inhibited SEA- and SEB-stimulated activation of PBMCs from patients with AD. Our findings encourage the use of lidocaine in the treatment of AD.Keywords
This publication has 45 references indexed in Scilit:
- Epidermal barrier dysfunction and cutaneous sensitization in atopic diseasesJournal of Clinical Investigation, 2012
- Analysis of Colonization and Genotyping of the Exotoxins ofStaphylococcus aureusin Patients with Atopic DermatitisAnnals of Dermatology, 2012
- Lidocaine suppresses mouse Peyer's Patch T cell functions and induces bacterial translocationSurgery, 2011
- Lidocaine‐derivative JMF2‐1 prevents ovalbumin‐induced airway inflammation by regulating the function and survival of T cellsClinical & Experimental Allergy, 2010
- Staphylococcal EnterotoxinsToxins, 2010
- Lidocaine inhibits epithelial chemokine secretion via inhibition of nuclear factor κB activationImmunobiology, 2010
- Changes of Antimicrobial Peptides and Transepidermal Water Loss After Topical Application of Tacrolimus and Ceramide-dominant Emollient in Patients with Atopic DermatitisJournal of Korean Medical Science, 2010
- Lidocaine down-regulates nuclear factor-κB signalling and inhibits cytokine production and T cell proliferationClinical and Experimental Immunology, 2008
- Cytokine modulation of atopic dermatitis filaggrin skin expressionJournal of Allergy and Clinical Immunology, 2007
- Short-Term Glucocorticoid Treatment Compromises Both Permeability Barrier Homeostasis and Stratum Corneum Integrity: Inhibition of Epidermal Lipid Synthesis Accounts for Functional AbnormalitiesJournal of Investigative Dermatology, 2003